IL137995A0 - Method of producing mouse and human endostatin - Google Patents

Method of producing mouse and human endostatin

Info

Publication number
IL137995A0
IL137995A0 IL13799599A IL13799599A IL137995A0 IL 137995 A0 IL137995 A0 IL 137995A0 IL 13799599 A IL13799599 A IL 13799599A IL 13799599 A IL13799599 A IL 13799599A IL 137995 A0 IL137995 A0 IL 137995A0
Authority
IL
Israel
Prior art keywords
human endostatin
producing mouse
mouse
producing
endostatin
Prior art date
Application number
IL13799599A
Other languages
English (en)
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of IL137995A0 publication Critical patent/IL137995A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13799599A 1998-02-23 1999-02-19 Method of producing mouse and human endostatin IL137995A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7558798P 1998-02-23 1998-02-23
PCT/US1999/003271 WO1999042486A1 (en) 1998-02-23 1999-02-19 Method of producing mouse and human endostatin

Publications (1)

Publication Number Publication Date
IL137995A0 true IL137995A0 (en) 2001-10-31

Family

ID=22126741

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13799599A IL137995A0 (en) 1998-02-23 1999-02-19 Method of producing mouse and human endostatin

Country Status (15)

Country Link
US (1) US6653098B1 (cs)
EP (1) EP1056780A1 (cs)
JP (1) JP2002504494A (cs)
KR (1) KR20010034529A (cs)
CN (1) CN1295580A (cs)
AU (1) AU766154C (cs)
BR (1) BR9908186A (cs)
CA (1) CA2321958A1 (cs)
CZ (1) CZ20003058A3 (cs)
IL (1) IL137995A0 (cs)
NO (1) NO20004170L (cs)
NZ (1) NZ506466A (cs)
PL (1) PL342495A1 (cs)
RU (1) RU2225728C2 (cs)
WO (1) WO1999042486A1 (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) * 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
AU4182300A (en) * 1999-03-30 2000-10-16 Merck & Co., Inc. Soluble recombinant endostatin
AU2001236951A1 (en) * 2000-02-18 2001-08-27 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Method for refolding recombinant endostatin
IL152804A0 (en) * 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
US7276580B2 (en) 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
WO2004094592A2 (en) 2003-04-18 2004-11-04 Biogen Idec Ma Inc. Polymer-conjugated glycosylated neublastin
DE602004015142D1 (de) * 2003-08-29 2008-08-28 Childrens Medical Center Antiangiogene peptide zur behandlung oder vorbeugung von endometriose
US7524811B2 (en) * 2003-08-29 2009-04-28 Children's Medical Center Corporation Anti-angiogenic peptides from the N-terminus of endostatin
DK1786454T3 (da) 2004-08-19 2010-09-06 Biogen Idec Inc Neublastinvarianter
CA2577690C (en) 2004-08-19 2013-08-06 Biogen Idec Ma Inc. Refolding transforming growth factor beta family proteins
RU2278688C1 (ru) * 2004-12-02 2006-06-27 Сергей Викторович Луценко Препарат человеческого эндостатина и способ его получения
BRPI0621124A2 (pt) 2005-12-22 2011-11-29 Genentech Inc métodos para recuperação de uma proteìna de ligação à heparina
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
CN100398557C (zh) * 2006-04-05 2008-07-02 中国药科大学 血管生成抑制多肽及其制备方法和应用
AR062069A1 (es) * 2006-07-14 2008-10-15 Genentech Inc Replegado de proteinas recombinantes
BRPI0605212B8 (pt) * 2006-12-12 2021-05-25 Univ Rio De Janeiro processo de produção de endostatina dimerizada ou oligomerizada, endostatina dimerizada ou oligomerizada e composição farmacêutica
WO2008076933A2 (en) * 2006-12-14 2008-06-26 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same
EP2142205B1 (en) 2007-05-01 2014-04-02 Biogen Idec MA Inc. Neublastin peptides for use in increasing vascularisation in tissue with impaired blood flow
EP3366692A1 (en) 2009-06-22 2018-08-29 Amgen, Inc Refolding proteins using a chemically controlled redox state
AU2010266093B2 (en) 2009-06-25 2013-06-27 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
WO2013012770A2 (en) * 2011-07-19 2013-01-24 Wenlin Huang Process for producing recombinant human endostatin adenovirus
CN103992400B (zh) * 2014-05-29 2017-01-04 江苏吴中医药集团有限公司苏州中凯生物制药厂 重组人血管内皮抑素的复性液及其制备、使用方法
PE20170769A1 (es) * 2014-07-14 2017-07-04 Gennova Biopharmaceuticals Ltd Procedimiento novedoso para la purificacion de rhu-gcsf
CN106008702B (zh) * 2016-07-22 2019-11-26 江苏江山聚源生物技术有限公司 一种规模化分离纯化重组人源胶原蛋白的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537708A1 (de) 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
JPH01132598A (ja) 1987-10-14 1989-05-25 Pitman Moore Inc 変性剤溶液中に含まれる組換え蛋白質における分子内ジスルフィド結合の生成を促進する方法
US5789547A (en) 1995-06-07 1998-08-04 Celtrix Pharmaceuticals, Inc. Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
US5854205A (en) * 1995-10-23 1998-12-29 The Children's Medical Center Corporation Therapeutic antiangiogenic compositions and methods
JP3840262B2 (ja) 1995-10-23 2006-11-01 ザ チルドレンズ メディカル センター コーポレイション 治療用の抗血管新生組成物および方法
SE9504019D0 (sv) 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins

Also Published As

Publication number Publication date
WO1999042486A1 (en) 1999-08-26
NZ506466A (en) 2003-10-31
AU3294599A (en) 1999-09-06
KR20010034529A (ko) 2001-04-25
RU2225728C2 (ru) 2004-03-20
BR9908186A (pt) 2000-10-24
CZ20003058A3 (cs) 2001-09-12
EP1056780A1 (en) 2000-12-06
NO20004170D0 (no) 2000-08-21
US6653098B1 (en) 2003-11-25
JP2002504494A (ja) 2002-02-12
PL342495A1 (en) 2001-06-04
NO20004170L (no) 2000-10-23
AU766154C (en) 2004-05-20
AU766154B2 (en) 2003-10-09
CN1295580A (zh) 2001-05-16
CA2321958A1 (en) 1999-08-26

Similar Documents

Publication Publication Date Title
IL137995A0 (en) Method of producing mouse and human endostatin
GB2347685B (en) NiTi-based medical guidewire and method of producing the same
ZA984483B (en) Ozone generator and method of producing ozone
PL318128A1 (en) Polymer-polyol and method of obtaining polymer-polyols
GB2345948B (en) Spiral formed products and method of manufacture
PL332072A1 (en) L-glutamic acid producing micro-organism and method of obtaining l-glutamic acid
PL332071A1 (en) L-glutamic acid producing micro-organism and method of obtaining l-glutamic acid
PL319213A1 (en) Partially hydrophobous precipitated silic acids, method of obtaining them and their application
PL335903A1 (en) Improved method of obtaining thiazolydinodiones and novel thiazolydinodiones obtained thereby
PL337716A1 (en) Method of obtaining thiazafurin and other c-nucleosides
HU9700991D0 (en) Taxoid derivatives and method of producing thereof
GB9706070D0 (en) Method of decomposing polychlorodibenzo-p-dioxins and/or polychlorodibenzofurans
TW297218U (en) Glove and method of producing same
HUP9700441A3 (en) Process for producing and using of (3-alcoxy-phenyl)-magnesium-chlorides
GB9909411D0 (en) Medio-surgical tubes and methods of manufacture
PL342185A1 (en) Modified psilium and method of obtaining same
PL343396A1 (en) Latticework and method of making same
PL341763A1 (en) Triazepinones, method of obtaining them and their therapeutic application
PL326573A1 (en) Novel paragene and method of obtaining same
GB2338676B (en) Apertured headrest and method of producing same
IL139497A0 (en) Carboxylic cationites and methods of manufacture
EP0975265A4 (en) CURVED SURGICAL NEEDLE AND THEIR PRODUCTION PROCESS
PL324948A1 (en) Novel terpenoidic spirolacton and method of obtaining same
PL327421A1 (en) Novel hydroxylactones and method of obtaining them
IL119931A0 (en) An improved jewelry construction and method of manufacture